J&J, Goldman stocks cut Dow’s price by 68 points after earnings

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

Shares of Johnson & Johnson and Goldman Sachs Group Inc. were the biggest drags on the Dow Jones Industrial Average even as both companies reported...

Shares of Johnson & Johnson JNJ and Goldman Sachs Group Inc. GS were the biggest drags on the Dow Jones Industrial Average DJIA, even as both companies reported first-quarter profit that topped expectations. J&J’s stock fell $3.92, or 2.4%, as the drug maker recorded a large charge as it settled lawsuits stemming from its talc-containing powders. Goldman’s stock shed $6.37, or 1.9, after the banker and broker’s profit beat, but revenue fell short. The two stocks’ combined $10.

... Shares of Johnson & Johnson JNJ and Goldman Sachs Group Inc. GS were the biggest drags on the Dow Jones Industrial Average DJIA , even as both companies reported first-quarter profit that topped expectations. J&J’s stock fell $3.92, or 2.4%, as the drug maker recorded a large charge as it settled lawsuits stemming from its talc-containing powders. Goldman’s stock shed $6.37, or 1.9, after the banker and broker’s profit beat, but revenue fell short. The two stocks’ combined $10.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in CA

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and moreShares of Goldman Sachs shed nearly 4% after missing revenue estimates in its first-quarter earnings released before Tuesday's opening bell. JnJ tanking…probably because Jim Cramer opened his mouth. Whatever stock he mentions, tanks📉📉📉.
Source: CNBC - 🏆 12. / 72 Read more »

Johnson & Johnson beats on earnings and revenue, raises full-year guidanceEARNINGS: J&J reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year forecast. CFO Joseph Wolk joins us to discuss. Nothing on Liability on talc? Texas 2 step shouldn’t be allowed So they should stop using shell game bankruptcy strategies to avoid their legal responsibilities to women their product harmed.
Source: CNBC - 🏆 12. / 72 Read more »